Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation-Reference-Cited by-同舟云学术

Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation

Published:2013-03 Issue:12 Volume:288 Page:8279-8288
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Kosenko Tanja,Golder Mia,Leblond Geoffrey,Weng Willy,Lagace Thomas A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference52 articles.

1. The LDL receptor;Goldstein;Arterioscler. Thromb. Vasc. Biol.,2009

2. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia;Hobbs;Hum. Mutat.,1992

3. Familial defective apolipoprotein B-100. A mutation of apolipoprotein B that causes hypercholesterolemia;Innerarity;J. Lipid Res.,1990

4. Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease;Abifadel;Hum. Mutat.,2009

5. PCSK9. A convertase that coordinates LDL catabolism;Horton;J. Lipid Res.,2009

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of proprotein convertase subtilisin/kexin 9 (PCSK9) in macrophage activation: a focus on its LDL receptor-independent mechanisms;Frontiers in Cardiovascular Medicine;2024-08-01

2. Cholesterol reduction by immunization with a PCSK9 mimic;Cell Reports;2024-06

3. Effect of anti-PCSK9 drugs on the association of PCSK9 to LDL;European Atherosclerosis Journal;2024-04-30

4. The CRISPR-Cas technology: trends in healthcare;CRISPR-Cas System in Translational Biotechnology;2024

5. LOX-1 variants modulate the severity of cardiovascular disease: state of the art and future directions;Molecular and Cellular Biochemistry;2023-10-03